Biotech Momentum in 89 Bio Amid Roche Acquisition Talk
about 1 month ago
Team Commentary
"I want to mention a company we don't talk about it, 89 Bio, tickers ETNB. This stock up 85% in today's session... Roche, and this kind of plays into this whole subject and area of weight loss drugs. Roche said it will acquire this biopharmaceutical company for up to $3.5 billion."
89 Bio (ETNB) saw an explosive 85% surge in trading, drawing attention amid Roche's potential acquisition announcement worth up to $3.5 billion, which could bolster Roche's obesity treatment pipeline.
Scores
Alpha Potential
8.0/10
Novelty
8.0/10
Credibility
7.0/10
Timeliness
9.0/10
Overall
8.0/10
Sentiment
Bullish
Conviction
High
Tier
Company Commentary
Related Stocks
Episode Information
Episode:
Closing Bell: Intel Rallies, Novo Nordisk Jumps, FedEx Sees Sales Growth
Source:Stock Movers
Published:
September 18, 2025
Idea Type:
Mergers & Acquisitions